Skip to main content
Top
Published in: Indian Journal of Pediatrics 4/2012

01-04-2012 | Clinical Brief

Essential Thrombocytosis and Antiphospholipid Antibody Syndrome Causing Chronic Budd-Chiari Syndrome

Authors: Dinesh Yadav, Jagdish Chandra, Sunita Sharma, Varinder Singh

Published in: Indian Journal of Pediatrics | Issue 4/2012

Login to get access

Abstract

Essential thrombocytosis is extremely rare in children. However, when present, it is associated with increased prevalence of antiphospholipid antibodies and thrombo-hemorrhagic complications. The authors report here a child with Budd-Chiari Syndrome resulting from essential thrombocytosis and associated antiphospholipid antibodies. A 13- y-old boy presented with microcytic hypochromic anemia, hepatosplenomegaly and thrombocytosis. CT scan demonstrated calcified thrombus in inferior vena cava (IVC). Diagnosis of essential thrombocytosis was considered in view of persistent thrombocytosis, antiphospholipid antibodies, bone marrow showing increased number, clusters and giant forms of megakaryocytes and IVC thrombosis. He was started on warfarin prophylaxis and did not have thrombotic recurrence on follow up.
Literature
1.
go back to reference Dame C, Sutor AH. Primary and secondary thrombocytosis in childhood. Br J Haematol. 2005;129:165–77.PubMedCrossRef Dame C, Sutor AH. Primary and secondary thrombocytosis in childhood. Br J Haematol. 2005;129:165–77.PubMedCrossRef
2.
go back to reference Campbell PJ, Green AR. Management of polycythemia vera and essential thrombocythemia. Hematol Am Soc Hematol Educ Program. 2005;1:201–8.CrossRef Campbell PJ, Green AR. Management of polycythemia vera and essential thrombocythemia. Hematol Am Soc Hematol Educ Program. 2005;1:201–8.CrossRef
3.
go back to reference Jantunen R, Juvonen E, Ikkala E, et al. Essential thrombocythemia at diagnosis: causes of diagnostic evaluation and presence of positive diagnostic findings. Ann Hematol. 1998;77:101–6.PubMedCrossRef Jantunen R, Juvonen E, Ikkala E, et al. Essential thrombocythemia at diagnosis: causes of diagnostic evaluation and presence of positive diagnostic findings. Ann Hematol. 1998;77:101–6.PubMedCrossRef
4.
go back to reference Harrison CN, Donohoe S, Carr P, et al. Patients with essential thrombocythaemia have an increased prevalence of antiphospholipid antibodies which may be associated with thrombosis. Thromb Haemost. 2002;87:802–7.PubMed Harrison CN, Donohoe S, Carr P, et al. Patients with essential thrombocythaemia have an increased prevalence of antiphospholipid antibodies which may be associated with thrombosis. Thromb Haemost. 2002;87:802–7.PubMed
5.
go back to reference Ravelli A, Martini A. Antiphospholipid Syndrome. Pediatr Clin N Am. 2005;52:469–91.CrossRef Ravelli A, Martini A. Antiphospholipid Syndrome. Pediatr Clin N Am. 2005;52:469–91.CrossRef
6.
go back to reference Galli M, Luciani D, Bertolini G, et al. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood. 2003;101:1827–32.PubMedCrossRef Galli M, Luciani D, Bertolini G, et al. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood. 2003;101:1827–32.PubMedCrossRef
7.
go back to reference Ortel TL. Thrombosis and the antiphospholipid syndrome. Hematol Am Soc Hematol Educ Program. 2005;1:462–8.CrossRef Ortel TL. Thrombosis and the antiphospholipid syndrome. Hematol Am Soc Hematol Educ Program. 2005;1:462–8.CrossRef
8.
go back to reference Senzolo M, Cholongitas EC, Patch D, et al. Update on the classification, assessment of prognosis and therapy of Budd–Chiari syndrome. Nat Clin Pract Gastroenterol Hepatol. 2005;2:182–90.PubMedCrossRef Senzolo M, Cholongitas EC, Patch D, et al. Update on the classification, assessment of prognosis and therapy of Budd–Chiari syndrome. Nat Clin Pract Gastroenterol Hepatol. 2005;2:182–90.PubMedCrossRef
9.
go back to reference Horton JD, San Miguel FL, Ortiz JA. Budd Chiari syndrome: illustrated review of current management. Liver Int. 2008;28:455–68.PubMedCrossRef Horton JD, San Miguel FL, Ortiz JA. Budd Chiari syndrome: illustrated review of current management. Liver Int. 2008;28:455–68.PubMedCrossRef
10.
go back to reference Pelletier S, Landi B, Piette JC, et al. Antiphospholipid antibody syndrome as the second cause of non-tumorous Budd-Chiari syndrome. J Hepatol. 1994;21:76–80.PubMedCrossRef Pelletier S, Landi B, Piette JC, et al. Antiphospholipid antibody syndrome as the second cause of non-tumorous Budd-Chiari syndrome. J Hepatol. 1994;21:76–80.PubMedCrossRef
Metadata
Title
Essential Thrombocytosis and Antiphospholipid Antibody Syndrome Causing Chronic Budd-Chiari Syndrome
Authors
Dinesh Yadav
Jagdish Chandra
Sunita Sharma
Varinder Singh
Publication date
01-04-2012
Publisher
Springer-Verlag
Published in
Indian Journal of Pediatrics / Issue 4/2012
Print ISSN: 0019-5456
Electronic ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-011-0550-6

Other articles of this Issue 4/2012

Indian Journal of Pediatrics 4/2012 Go to the issue

Symposium on PGIMER Protocols in Neurological Emergencies

Management of Acute Seizure and Status Epilepticus in Pediatric Emergency